No Data
No Data
Here's Why Hunan Jiudian Pharmaceutical (SZSE:300705) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' It's only natural to co
Jiudian Pharmaceutical (300705.SZ) announced its 2023 annual results. Net profit of 368 million yuan increased 36.54% year over year
Jiudian Pharmaceutical (300705.SZ) released its 2023 annual performance report. The company achieved operating income during the reporting period...
Hunan Jiudian Pharmaceutical Co., Ltd.'s (SZSE:300705) Stock Is Going Strong: Is the Market Following Fundamentals?
Hunan Jiudian Pharmaceutical (SZSE:300705) has had a great run on the share market with its stock up by a significant 11% over the last three months. Given the company's impressive performance, we d
Hunan Jiudian Pharmaceutical Co., Ltd.'s (SZSE:300705) Market Cap Increased by CN¥414m, Insiders Receive a 48% Cut
Key Insights Hunan Jiudian Pharmaceutical's significant insider ownership suggests inherent interests in company's expansion 52% of the business is held by the top 4 shareholders Institutional ow
Jiudian Pharmaceutical (300705.SZ): There are no export plans for topical pharmaceutical products
Gelonghui March 18 丨 Jiudian Pharmaceutical (300705.SZ) said at an investor relations event that the company has no export plans for topical pharmaceutical products.
Jiudian Pharmaceutical (300705.SZ): Judging from the implementation in Guangdong Province and Henan Province, the exchange of price for volume has been achieved relatively well
Gelonghui, March 18 | Jiudian Pharmaceutical (300705.SZ) said at an investor relations event that the collection of loxoprofen sodium gel patches has basically been carried out in the Guangdong Union region. Judging from the implementation in Guangdong Province and Henan Province, the exchange of price for volume has been achieved quite well. The collection of loxoprofen sodium gel patch in Zhejiang Province has not yet been implemented. The company expects to further expand the sales scope of this product after implementation, increase its market share, enhance the company's brand influence, and have a positive impact on the company's long-term development. Loxoprofen sodium gel patch is currently only available in the Beijing-Tianjin-Hebei “3+N” Alliance Drug Centralized Procurement Alliance provinces
No Data